21/09/2025
💨 Lung Cancer Clinical Trials Open for Enrollment at China's Leading Cancer Center! 💨
Fighting lung cancer—non-small cell (NSCLC), small-cell (SCLC), or metastatic?
The Cancer Center at the Chinese Academy of Medical Sciences (CAMS) is now recruiting patients for international lung cancer clinical trials, including:
✅ Immunotherapy (PD-1, PD-L1 inhibitors)
✅ Targeted therapies (EGFR, ALK, KRAS, MET, ROS1, RET, etc.)
✅ Cellular therapies (CEA CAR-T, TCR-T, TIL therapy)
✅ Trials for advanced, drug-resistant, or relapsed cases
✅ Combination therapies with chemo, radiation, or biologics
🌍 Open to patients from India, Southeast Asia, CIS countries, Middle East, and Europe
💬 English-speaking care coordinators | Affordable pricing | Fast evaluation and admission
📩 Apply Now!
📲 Send your medical reports on WhatsApp: +86 182 1759 2149
Don't wait. Access innovative treatments that can make a difference.